Allo-immunization elicits CD8+ T cell-derived chemokines, HIV suppressor factors and resistance to HIV infection in women.

Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Allo-immunization elicits CD8+ T cell-derived chemokines, HIV suppressor factors and resistance to HIV infection in women.

Nat Med. 1999 Sep;5(9):1004-9. Unique Identifier : AIDSLINE MED/99401079
Wang Y; Tao L; Mitchell E; Bravery C; Berlingieri P; Armstrong P; Vaughan R; Underwood J; Lehner T; Department of Immunobiology, Guy's, King's and St. Thomas'; Medical and Dental Schools at Guy's Hospital, Medical School; Building, 3rd Floor, London SE1 9RT, UK.

Abstract: We assessed the potential for an allogeneic-based vaccine against HIV infection in women who were allo-immunized with their partners' mononuclear leucocytes to prevent spontaneous recurrent abortion. Within 1 month of allo-immunization, there was significant upregulation in the concentrations of CD8 cell-derived suppressor factor activity, RANTES, and macrophage inflammatory proteins 1alpha and 1beta. Allo-immunization also downregulated the proportion of cells with CCR5 and CXCR4 receptors. We also found a dose-dependent decrease in HIV infectivity of CD4+ cells in vitro after allo-immunization with both primary and T-cell line adapted HIV-1. This study provides a rational basis for an alternative or complementary strategy of allo-immunization against HIV infection.

Keywords: JOURNAL ARTICLE Abortion, Habitual/IMMUNOLOGY/THERAPY Antigens, CD4/IMMUNOLOGY/METABOLISM Cells, Cultured Chemokines, CC/IMMUNOLOGY/*METABOLISM CD4-Positive T-Lymphocytes/IMMUNOLOGY/VIROLOGY CD8-Positive T-Lymphocytes/*IMMUNOLOGY Female Gene Expression Regulation Human HIV Infections/IMMUNOLOGY HIV-1/IMMUNOLOGY/*PHYSIOLOGY *Immunization Isoantibodies/*IMMUNOLOGY Leukocytes, Mononuclear/IMMUNOLOGY/TRANSPLANTATION Macrophage Inflammatory Protein-1/METABOLISM Male Pregnancy Receptors, CCR5/METABOLISM Receptors, CXCR4/METABOLISM RANTES/METABOLISM Support, Non-U.S. Gov't Suppressor Factors, Immunologic/IMMUNOLOGY/*METABOLISM Virus Replication
991230
A99C1015

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .